Choline transporter CHT regulation and function in cholinergic neurons

Central Nervous System Agents in Medicinal Chemistry

Volumn 12, Issue 2, 2012, Pages 114-121

  Black, Stefanie A G ^a   Rylett, R Jane ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Acetylcholine; Choline; Cholinergic; High affinity choline uptake; Neurons; Phosphorylation; Protein protein interactions; Subcellular trafficking

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; CARRIER PROTEIN; CHOLINE; CHOLINE TRANSPORTER; MESSENGER RNA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINE TRANSPORT; AMINO ACID SEQUENCE; ARTICLE; ATTENTION DEFICIT DISORDER; CHOLINERGIC NERVE CELL; CHOLINERGIC TRANSMISSION; DEPOLARIZATION; ENZYME INHIBITION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HUMAN; HUNTINGTON CHOREA; HYPOGLOSSAL NERVE; INTRACELLULAR TRANSPORT; MOLECULAR CLONING; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84862530942     PISSN: 18715249     EISSN: 18756166     Source Type: Journal    
DOI: 10.2174/187152412800792724     Document Type: Article

References (97)

1. Woolf, N. J.; Butcher, L. L. Cholinergic systems mediate action from movement to higher consciousness. Behav. Brain Res., 2011, 221, 488-498.
2. Okuda, T.; Haga, T.; Kanai, Y.; Endou, H.; Ishihara, T.; Katsura, I. Identification and characterization of the high-affinity choline transporter. Nat. Neurosci., 2000, 3, 120-125.
3. Ferguson, S.M.; Bazalakova, M.; Savchenko, V.; Tapia, J.C.; Wright, J.; Blakely, R.D. Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice. Proc. Natl. Acad. Sci., U.S.A. 2004, 101, 8762-8767.
4. Apparsundaram, S.; Ferguson, S. M.; George, A. L. jr.; Blakely, R. D. Molecular cloning of a human hemicholinium-3-sensitive choline transporter. Biochem. Biophys. Res. Commun., 2000, 276, 862-867.
5. Okuda, T.; Haga, T. Functional characterization of the human highaffinity choline transporter. FEBS Lett., 2000, 484, 92-97.
6. Apparsundaram, S.; Ferguson, S. M.; Blakely, R. D. Molecular cloning and characterization of a murine hemicholinium-3-sensitive choline transporter. Biochem. Soc. Trans., 2001, 29, 711-716.
7. Wang, Y.; Cao, Z.; Newkirk, R. F.; Ivy, M. T.; Townsel, J. G. Molecular cloning of a cDNA for a putative choline co-transporter from Limulus CNS. Gene, 2001, 268, 123-131.
8. McLean, H.; Verellen, L.; Caveney, S.; Donly, C. Molecular cloning and functional characterization of a neuronal choline transporter from Trichoplusiani. Insect. Biochem. Mol. Biol., 2005, 35, 61-72.
9. Ducis, I. The high affinity choline uptake system. Handb. Exp. Pharmacol,. 1988, 86, 409-437.
10. Ferguson, S. M.; Blakely, R. D. The choline transporter resurfaces: new roles for synaptic vesicles? Mol. Interv., 2004, 4, 22-37.
11. Misawa, H.; Nakata, K.; Matsuura, J.; Nagao, M.; Okuda, T.; Haga, T. Distribution of the high-affinity choline transporter in the central nervous system of the rat. Neuroscience, 2001, 105, 87-98.
12. Lips, K.S.; Pfeil, U.; Haberberger, R.V.; Kummer, W. Localisation of the high-affinity choline transporter-1 in the rat skeletal motor unit. Cell Tissue Res., 2002, 307, 275-280.
13. Kobayashi, Y.; Okuda, T.; Fujioka, Y.; Matsumura, G.; Nishimura, Y.; Haga, T. Distribution of the high-affinity choline transporter in the human and macaque monkey spinal cord. Neurosci. Lett., 2002, 317, 25-28.
14. Ferguson, S.M.; Savchenko, V.; Apparsundaram, S.; Zwick, M.; Wright, J.; Heilman, C. J.; Yi, H.; Levey, A. I.; Blakely, R. D. Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. J. Neurosci., 2003, 23, 9697-9709.
15. Kus, L.; Borys, E.; Ping Chu, Y.; Ferguson, S. M.; Blakely, R. D.; Emborg, M. E.; Kordower, J. H.; Levey, A. I.; Mufson, E. J. Distribution of high affinity choline transporter immunoreactivity in the primate central nervous system. J. Comp. Neurol., 2003, 463, 341-357.
16. Hoover, D. B.; Ganote, C. E.; Ferguson, S. M.; Blakely, R. D.; Parsons, R. L. Localization of cholinergic innervation in guinea pig heart by immunohistochemistry for high-affinity choline transporters. Cardiovasc. Res., 2004, 62, 112-121.
17. Nakata, K.; Okuda, T.; Misawa, H. Ultrastructural localization of high-affinity choline transporter in the rat neuromuscular junction: enrichment on synaptic vesicles. Synapse, 2004, 53, 53-56.
18. Oda, Y.; Muroishi, Y.; Misawa, H.; Suzuki, S. Comparative study of gene expression of cholinergic system-related molecules in the human spinal cord and term placenta. Neuroscience, 2004, 128, 39-49.
19. Bergeron, A. L.; Schrader, A.; Yang, D.; Osman, A. A.; Simmons, D. D. The final stage of cholinergic differentiation occurs below inner hair cells during development of the rodent cochlea. J. Assoc. Res. Otolaryngol., 2005, 6, 401-415.
20. Guidry, G.; Willison, B. D.; Blakely, R.D.; Landis, S.C.; Habecker, B. A. Developmental expression of the high affinity choline transporter in cholinergic sympathetic neurons. Auton. Neurosci., 2005, 123, 54-61.
21. Holmstrand, E.C.; Asafu-Adjei, J.; Sampson, A. R.; Blakely, R. D.; Sesack, S.R. Ultrastructural localization of high-affinity choline transporter in the rat anteroventral thalamus and ventral tegmental area: differences in axon morphology and transporter distribution. J. Comp. Neurol., 2010, 518, 1908-1924.
22. Lecomte, M. J.; De Gois, S.; Guerci, A.; Ravassard, P.; Faucon Biguet, N.; Mallet, J.; Berrard, S. Differential expression and regulation of the high-affinity choline transporter CHT1 and choline acetyltransferase in neurons of superior cervical ganglia. Mol. Cell Neurosci., 2005, 28, 303-313.
23. Fujii, T.; Okuda, T.; Haga, T.; Kawashima, K. Detection of the high-affinity choline transporter in the MOLT-3 human leukemic T-cell line. Life Sci., 2003, 72, 2131-2134.
24. Pfeil, U.; Haberberger, R. V.; Lips, K. S.; Eberling, L.; Grau, V.; Kummer, W. Expression of the high-affinity choline transporter CHT1 in epithelia. Life Sci., 2003, 72, 2087-2090.
25. Wessler, I.; Kirkpatrick, C. J. Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br. J. Pharmacol., 2008, 154, 1558-1571.
26. Hecker, A.; Mikulski, Z.; Lips, K. S.; Pfeil, U.; Zakrzewicz, A.; Wilker, S.; Hartmann, P.; Padberg, W.; Wessler, I.; Kummer, W.; Grau, V. Pivotal Advance: Up-regulation of acetylcholine synthesis and paracrine cholinergic signaling in intravascular transplant leukocytes during rejection of rat renal allografts. J. Leukoc. Biol., 2009, 86, 13-22.
27. Horiguchi, K.; Horiguchi, S.; Yamashita, N.; Irie, K.; Masuda, J.; Takano-Ohmuro, H.; Himi, T.; Miyazawa, M.; Moriwaki, Y.; Okuda, T.; Misawa, H.; Ozaki, H.; Kawashima, K. Expression of SLURP-1, an endogenous alpha7 nicotinic acetylcholine receptor allosteric ligand, in murine bronchial epithelial cells. J. Neurosci. Res., 2009, 87, 2740-2747.
28. Rana, O. R.; Schauerte, P.; Kluttig, R.; Schröder, J. W.; Koenen, R. R.; Weber, C.; Nolte, K. W.; Weis, J.; Hoffmann, R.; Marx, N.; Saygili, E. Acetylcholine as an age-dependent non-neuronal source in the heart. Auton. Neurosci., 2010, 156, 82-89.
29. Delbro, D. S.; Hallsberg, L.; Wallin, M.; Gustafsson, B. I.; Friman, S. Expression of the non-neuronal cholinergic system in rat liver. A. P. M. I. S. 2011, 119, 227-228.
30. Maeda, S.; Jun, J. G.; Kuwahara-Otani, S.; Tanaka, K.; Hayakawa, T.; Seki, M. Non-neuronal expression of choline acetyltransferase in the rat kidney. Life Sci., 2011, 89(11/12), 408-414
31. Schirmer, S. U.; Eckhardt, I.; Lau, H.; Klein, J.; Degraaf, Y. C.; Lips, K. S.; Pineau, C.; Gibbins, I. L.; Kummer, W.; Meinhardt, A.; Haberberger, R. V. The cholinergic system in rat testis is of nonneuronalorigin. Reproduction, 2011, 142, 157-166.
32. Ribeiro, F. M.; Black, S. A.; Cregan, S. P.; Prado, V. F.; Prado, M. A.; Rylett, R. J.; Ferguson, S. S. Constitutive high-affinity choline transporter endocytosis is determined by a carboxyl-terminal tail dileucine motif. J. Neurochem., 2005, 94, 86-96.
33. Sitte, H. H.; Farhan, H.; Javitch, J. A. Sodium-dependent neurotransmitter transporters: oligomerization as a determinant of transporter function and trafficking. Mol. Interv., 2004, 4, 38-47.
34. Berse, B.; Szczecinska, W.; Lopez-Coviella, I.; Madziar, B.; Zemelko, V.; Kaminski, R.; Kozar, K.; Lips, K. S.; Pfeil, U.; Blusztajn, J. K. Expression of high affinity choline transporter during mouse development in vivo and its upregulation by NGF and BMP-4 in vitro. Dev. Brain Res., 2005, 157, 132-140.
35. Madziar, B.; Shah, S.; Brock, M.; Burke, R.; Lopez-Coviella, I.; Nickel, A. C.; Cakal, E. B.; Blusztajn, J. K.; Berse, B. Nerve growth factor regulates the expression of the cholinergic locus and the high-affinity choline transporter via the Akt/PKB signaling pathway. J. Neurochem., 2008, 107, 1284-1293.
36. Brock, M.; Nickel, A. C.; Madziar, B.; Blusztajn, J. K.; Berse, B. Differential regulation of the high affinity choline transporter and the cholinergic locus by cAMP signaling pathways. Brain Res., 2007, 1145, 1-10.
37. Schnitzler, A. C.; Lopez-Coviella, I.; Blusztajn, J. K. Differential modulation of nerve growth factor receptor (p75) and cholinergic gene expression in purified p75-expressing and non-expressing basal forebrain neurons by BMP9. Brain Res., 2008, 1246, 19-28.
38. Oshima, S.; Yamada, K.; Shirakawa, T.; Watanabe, M. Changes of high-affinity choline transporter CHT1 mRNA expression during degeneration and regeneration of hypoglossal nerves in mice. Neurosci. Lett., 2004, 365, 97-101.
39. Mellott, T. J.; Kowall, N. W.; Lopez-Coviella, I.; Blusztajn, J. K. Prenatal choline deficiency increases choline transporter expression in the septum and hippocampus during postnatal development and in adulthood in rats. Brain Res., 2007, 1151, 1-11.
40. Mao, C.; Yuan, X.; Zhang, H.; Lv, J.; Guan, J.; Miao, L.; Chen, L.; Zhang, Y.; Zhang, L.; Xu, Z. The effect of prenatal nicotine on mRNA of central cholinergic markers and hematological parameters in rat fetuses. Int. J. Dev. Neurosci., 2008, 26, 467-475.
41. Kalogiannis, M.; Grupke, S.L.; Potter, P.E.; Edwards, J.G.; Chemelli, R.M.; Kisanuki, Y.Y.; Yanagisawa, M.; Leonard, C.S. Narcoleptic orexin receptor knockout mice express enhancedcholinergic properties in laterodorsal tegmental neurons. Eur. J. Neurosci., 2010, 32, 130-142.
42. Matsuo, A.; Bellier, J. P.; Nishimura, M.; Yasuhara, O.; Saito, N.; Kimura, H. Nuclear choline acetyltransferase activates transcription of a high-affinity choline transporter. J. Biol. Chem., 2011, 286, 5836-5845.
43. Brandon, E. P.; Mellott, T.; Pizzo, D. P.; Coufal, N.; D'Amour, K. A.; Gobeske, K.; Lortie, M.; López-Coviella, I.; Berse, B.; Thal, L. J.; Gage, F. H.; Blusztajn, J. K. Choline transporter 1 maintains cholinergic function in choline acetyltransferase haploinsufficiency. J. Neurosci., 2004, 24, 5459-5466.
44. de Castro, B. M.; De Jaeger, X.; Martins-Silva, C.; Lima, R. D. F.; Amaral, E.; Menezes, C.; Lima, P.; Neves, C. M.; Pires, R. G.; Gould, T. W.; Welch, I.; Kushmerick, C.; Guatimosim, C.; Izquierdo, I.; Cammarota, M.; Rylett, R. J.; Gomez, M. V.; Caron, M. G.; Oppenheim, R. W.; Prado, M. A.; Prado, V. F. The vesicular acetylcholine transporter is required for neuromuscular development and function. Mol. Cell Biol., 2009, 29, 5238-5250.
45. Bazalakova, M.H.; Wright, J.; Schneble, E.J.; McDonald, M.P.; Heilman, C.J.; Levey, A. I.; Blakely, R. D. Deficits in acetylcholine homeostasis, receptors and behaviors in choline transporter heterozygous mice. Genes Brain Behav., 2007, 6, 411-424.
46. English, B. A.; Appalsamy, M.; Diedrich, A.; Ruggiero, A. M.; Lund, D.; Wright, J.; Keller, N. R.; Louderback, K. M.; Robertson, D.; Blakely, R. D. Tachycardia, reduced vagal capacity, and agedependent ventricular dysfunction arising from diminished expression of the presynaptic choline transporter. Am. J. Physiol. Heart Circ. Physiol., 2010, 299, H799-H810.
47. Volpicelli-Daley, L. A.; Hrabovska, A.; Duysen, E. G.; Ferguson, S. M.; Blakely, R. D.; Lockridge, O.; Levey, A. I. Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice. Mol. Pharmacol., 2003, 64, 1309-1316.
48. Beeri, R.; Le Novère, N.; Mervis, R.; Huberman, T.; Grauer, E.; Changeux, J. P.; Soreq, H. Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired acetylcholinesterase-transgenic mice. J. Neurochem., 1997, 69, 2441-2451.
49. Rassadi, S.; Krishnaswamy, A.; Pié, B.; McConnell, R.; Jacob, M. H.; Cooper, E. A null mutation for the alpha3 nicotinic acetylcholine (ACh) receptor gene abolishes fast synaptic activity in sympathetic ganglia and reveals that ACh output from developing preganglionic terminals is regulated in an activitydependent retrograde manner. J. Neurosci., 2005, 25, 8555-8566.
50. Krishnaswamy, A.; Cooper, E. An activity-dependent retrograde signal induces the expression of the high-affinity choline transporter in cholinergic neurons. Neuron, 2009, 61, 272-286.
51. Ribeiro, F. M.; Alves-Silva, J.; Volknandt, W.; Martins-Silva, C.; Mahmud, H.; Wilhelm, A.; Gomez, M. V.; Rylett, R. J.; Ferguson, S. S.; Prado, V. F.; Prado, M. A. The hemicholinium-3 sensitive high affinity choline transporter is internalized by clathrinmediated endocytosis and is present in endosomes and synaptic vesicles. J. Neurochem., 2003, 87, 136-146.
52. Ribeiro, F. M.; Pinthong, M.; Black, S. A.; Gordon, A. C.; Prado, V. F.; Prado, M. A.; Rylett, R. J.; Ferguson, S. S. Regulated recycling and plasma membrane recruitment of the high-affinity choline transporter. Eur. J. Neurosci., 2007, 26, 3437-3448.
53. Apparsundaram, S.; Martinez, V.; Parikh, V.; Kozak, R.; Sarter, M. Increased capacity and density of choline transporters situated in synaptic membranes of the right medial prefrontal cortex of attentional task-performing rats. J. Neurosci., 2005, 25, 3851-3856.
54. Ivy, M. T.; Newkirk, R. F.; Wang, Y.; Townsel, J. G. A novel choline cotransporter sequestration compartment in cholinergic neurons revealed by selective endosomal ablation. J. Neurochem., 2010, 112, 1295-1304.
55. Breer, H.; Knipper, M. Regulation of high affinity choline uptake. J. Neurobiol., 1990, 21, 269-275.
56. Cancela, J. M.; Bertrand, N.; Beley, A. Involvement of cAMP in the regulation of high affinity choline uptake by rat brain synaptosomes. Biochem. Biophys. Res. Commun., 1995, 213, 944-949.
57. Vogelsberg, V.; Neff, N. H.; Hadjiconstantinou, M. Cyclic AMPmediated enhancement of high-affinity choline transport and acetylcholine synthesis in brain. J. Neurochem., 1997, 68, 1062-1070.
58. Knipper, M.; Kahle, M.; Breer, H. Regulation of hemicholinium binding sites in isolated nerve terminals. J. Neurobiol., 1992, 23, 163-172.
59. Ivy, M. T.; Newkirk, R. F.; Karim, M. R.; Mtshali, C. M.; Townsel, J. G. Hemicholinium-3 mustard reveals two populations of cycling choline cotransporters in Limulus. Neuroscience, 2001, 102, 969-978.
60. Gates, J. j.; Ferguson, S. M.; Blakely, R. D. Regulation of choline transporter surface expression and phosphorylation by protein kinase C and protein phosphatase 1/2. J. Pharmacol. Exp. Ther., 2004, 310, 536-545.
61. Black, S. A.; Ribeiro, F. M.; Ferguson, S. S.; Rylett, R. J. Rapid, transient effects of the protein kinase C activator phorbol 12- myristate 13-acetate on activity and trafficking of the rat highaffinity choline transporter. Neuroscience, 2010, 167, 765-773.
62. Cooke, L. J.; Rylett, R. J. Inhibitors of serine/threonine phosphatases increase membrane-bound choline acetyltransferase activity and enhance acetylcholine synthesis. Brain Res. 1997, 751, 232-238.
63. Issa, A. M.; Gauthier, S.; Collier, B. Effects of the phosphatase inhibitors calyculin A and okadaic acid on acetylcholine synthesis and content of rat hippocampal formation. J. Neurochem. 1996, 66, 1924-1932.
64. Guermonprez, L.; O'Regan, S.; Meunier, F. M.; Morot-Gaudry- Talarmain, Y. The neuronal choline transporter CHT1 is regulated by immunosuppressor-sensitive pathways. J. Neurochem. 2002, 82, 874-884.
65. Xie, J.; Guo, Q. Par-4 inhibits choline uptake by interacting with CHT1 and reducing its incorporation on the plasma membrane. J. Biol. Chem., 2004, 279, 28266-28275.
66. Ribeiro, F. M.; Ferreira, L. T.; Marion, S.; Fontes, S.; Gomez, M.; Ferguson, S. S.; Prado, M. A.; Prado, V. F. SEC14-like protein 1 interacts with cholinergic transporters. Neurochem. Int., 2007, 50, 356-364.
67. Bales, K. R.; Tzavara, E. T.; Wu, S.; Wade, M. R.; Bymaster, F. P.; Paul, S. M.; Nomikos, G. G. Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody. J. Clin. Invest., 2006, 116, 825-832.
68. Wang, B.; Yang, L.; Wang, Z.; Zheng, H. Amyloid precursor protein mediates presynaptic localization and activity of the highaffinity choline transporter. Proc. Natl. Acad. Sci. U.S.A., 2007, 104, 14140-14145.
69. Rylett, R. J.; Ball, M. J.; Colhoun, E. H. Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease. Brain Res., 1983, 289, 169-175.
70. Slotkin, T. A.; Seidler, F. J.; Crain, B. J.; Bell, J. M.; Bissette, G.; Nemeroff, C. B. Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: implications for etiology and therapy. Proc. Natl. Acad. Sci. U.S.A., 1990, 87, 2452-2455.
71. Pascual, J.; Fontán, A.; Zarranz, J. J.; Berciano, J.; Flórez, J.; Pazos, A. High-affinity choline uptake carrier in Alzheimer's disease: implications for the cholinergic hypothesis of dementia. Brain Res., 1991, 552, 170-174.
72. Rodríguez-Puertas, R.; Pazos, A.; Zarranz, J.J.; Pascual, J. Selective cortical decrease of high-affinity choline uptake carrier in Alzheimer's disease: an autoradiographic study using 3Hhemicholinium- 3. J. Neural Transm. Park. Dis. Dement. Sect., 1994, 8, 161-169.
73. Slotkin, T.A.; Nemeroff, C.B.; Bissette, G.; Seidler, F.J. Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies. J. Clin. Invest., 1994, 94, 696-702.
74. Kristofiková, Z.; Fales, E.; Majer, E.; Klaschka, J. (3H)hemicholinium-3 binding sites in postmortem brains of human patients with Alzheimer's disease and multi-infarct dementia. Exp. Gerontol. 1995, 30, 125-136.
75. Walsh, D.M.; Selkoe, D.J. A beta oligomers - a decade of discovery. J. Neurochem., 2007, 101, 1172-1184.
76. Kristofiková, Z.; Rícný, J.; Kozmiková, I.; Rípová, D.; Zach, P.; Klaschka, J. Sex-dependent actions of amyloid beta peptides on hippocampal choline carriers of postnatal rats. Neurochem. Res., 2006, 31, 351-360.
77. Kar, S.; Issa, A. M.; Seto, D.; Auld, D. S.; Collier, B.; Quirion, R. Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices. J. Neurochem., 1998, 70, 2179-2187.
78. Kristofiková, Z.; Tejkalová, H.; Klaschka, J. Amyloid beta peptide 1-40 and the function of rat hippocampal hemicholinium-3sensitive choline carriers: effects of a proteolytic degradation in vitro. Neurochem. Res., 2001, 26, 203-212.
79. Apelt, J.; Kumar, A.; Schliebs, R. Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein. Brain Res., 2002, 953, 17-30.
80. Klingner, M.; Apelt, J.; Kumar, A.; Sorger, D.; Sabri, O.; Steinbach, J.; Scheunemann, M.; Schliebs, R. Alterations in cholinergic and non-cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with beta-amyloid plaque pathology. Int. J. Dev. Neurosci., 2003, 21, 357-369.
81. Opazo, P.; Saud, K.; de Saint Pierre, M.; Cárdenas, A. M.; Allen, D. D.; Segura-Aguilar, J.; Caviedes, R.; Caviedes, P. Knockdown of amyloid precursor protein normalizes cholinergic function in a cell line derived from the cerebral cortex of a trisomy 16 mouse: An animal model of down syndrome. J. Neurosci. Res., 2006, 84, 1303-1310.
82. Payette, D. J.; Xie, J.; Guo, Q. Reduction in CHT1-mediated choline uptake in primary neurons from presenilin-1 M146V mutant knock-in mice. Brain Res., 2007, 1135, 12-21.
83. Kristofiková, Z.; Kopecký, V. J.; Hofbauerová, K.; Hovorková, P.; Rípová, D. Complex of amyloid beta peptides with 24- hydroxycholesterol and its effect on hemicholinium-3 sensitive carriers. Neurochem. Res., 2008, 33, 412-421.
84. Forgon, M.; Farkas, Z.; Gulya, K.; Pakaski, M.; Penke, B.; Kasa, P. Amyloid beta-peptide and its fragments induce acetylcholine release in in vitro basal forebrain tissue slices of rat brain, but do not affect the choline uptake. Neurobiology, 1998, 6, 359-361.
85. Melo, J. B.; Agostinho, P.; Oliveira, C. R. Amyloid beta-peptide 25-35 reduces [3H] acetylcholine release in retinal neurons. Involvement of metabolic dysfunction. Amyloid, 2002, 9, 221-228.
86. Hartmann, J.; Erb, C.; Ebert, U.; Baumann, K. H.; Popp, A.; König, G.; Klein, J. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice. Neuroscience, 2004, 125, 1009-1017.
87. Guermonprez, L.; Ducrocq, C.; Gaudry-Talarmain, Y. M. Inhibition of acetylcholine synthesis and tyrosine nitration induced by peroxynitrite are differentially prevented by antioxidants. Mol. Pharmacol., 2001, 60, 838-846.
88. Pinthong, M.; Black, S. A.; Ribeiro, F. M.; Pholpramool, C.; Ferguson, S. S.; Rylett, R. J. Activity and subcellular trafficking of the sodium-coupled choline transporter CHT is regulated acutely by peroxynitrite. Mol. Pharmacol., 2008, 73, 801-812.
89. Jomova, K.; Vondrakova, D.; Lawson, M.; Valko, M. Metals, oxidative stress and neurodegenerative disorders. Mol. Cell Biochem., 2010, 345, 91-104.
90. Vetter, J. M.; Jehle, T.; Heinemeyer, J.; Franz, P.; Behrens, P. F.; Jackisch, R.; Landwehrmeyer, G. B.; Feuerstein, T. J. Mice transgenic for exon 1 of Huntington's disease: properties of cholinergic and dopaminergic pre-synaptic function in the striatum. J. Neurochem., 2003, 85, 1054-1063.
91. Parikh, V.; Apparsundaram, S.; Kozak, R.; Richards, J. B.; Sarter, M. Reduced expression and capacity of the striatal high-affinity choline transporter in hyperdopaminergic mice. Neuroscience, 2006, 141, 379-389.
92. Okuda, T.; Okamura, M.; Kaitsuka, C.; Haga, T.; Gurwitz, D. Single nucleotide polymorphism of the human high affinity choline transporter alters transport rate. J. Biol. Chem., 2002, 277, 45315-45322.
93. Hahn, M. K.; Blackford, J. U.; Haman, K.; Mazei-Robison, M.; English, B. A.; Prasad, H. C.; Steele, A.; Hazelwood, L.; Fentress, H. M.; Myers, R.; Blakely, R. D.; Sanders-Bush, E.; Shelton, R. Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression. Genes Brain Behav., 2008, 7, 487-495.
94. Neumann, S. A.; Lawrence, E. C.; Jennings, J. R.; Ferrell, R. E.; Manuck, S. B. Heart rate variability is associated with polymorphic variation in the choline transporter gene. Psychosom. Med., 2005, 67, 168-171.
95. Neumann, S. A.; Brown, S. M.; Ferrell, R. E.; Flory, J. D.; Manuck, S. B.; Hariri, A. R. Human choline transporter gene variation is associated with corticolimbic reactivity and autonomiccholinergic function. Biol. Psychiatry, 2006, 60, 1155-1162.
96. Neumann, S. A.; Linder, K. J.; Muldoon, M. F.; Sutton-Tyrrell, K.; Kline, C.; Shrader, C. J.; Lawrence, E. C.; Ferrell, R. E.; Manuck, S. B. Polymorphic variation in choline transporter gene (CHT1) is associated with early, subclinical measures of carotid atherosclerosis in humans. Int. J. Cardiovasc. Imaging 2011, 28(27),243-50
97. English, B. A.; Hahn, M. K.; Gizer, I. R.; Mazei-Robison, M.; Steele, A.; Kurnik, D. M.; Stein, M. A.; Waldman, I. D.; Blakely, R. D. Choline transporter gene variation is associated with attention-deficit hyperactivity disorder. J. Neurodev. Disord., 2009, 1, 252-263.